Author's posts
No Surprises Act implementation includes telehealth
The No Surprises Act has providers scrambling to understand the implications of a law that went into effect earlier this month.
Under the law, patients treated by an out-of-network physician can only be billed at the in-network rate. It protects patien…
How health insurers are covering over-the-counter COVID-19 tests
Following recent guidance from the Biden Administration, health insurers in the commercial market are covering the costs of over-the-counter COVID-19 tests.
AHA is asking Congress to release remaining provider relief funds
The American Hospital Association wants Congressional action to distribute the remaining provider relief funds and to take other measures to help alleviate the financial strain caused by COVID-19.
HHS awards $103 million to fight workforce burnout and promote mental health
Forty-five organizations are getting the American Rescue Plan funds over three years.
Omicron likely to peak in mid-February, Fauci says
Omicron will likely peak in most states by mid-February, according to Dr. Anthony Fauci, chief medical advisor to the president.
Public health emergency extended another 90 days
The Department of Health and Human Services has renewed the public health emergency for the eighth time due to the COVID-19 pandemic.
On Friday, HHS Secretary Xavier Becerra issued the renewal for another 90 days.
CMS sets March 15 deadline for healthcare workers to get vaccinated
The Centers for Medicare and Medicaid Services has set a deadline of March 15 for healthcare workers to get vaccinated.
Supreme Court split in rulings over vaccine mandates
The Supreme Court was split in two rulings handed up Thursday over federal COVID-19 vaccine mandates.
The Justices ruled against the Biden Administration’s mandate that employees of large companies either get vaccinated or get tested weekly. They uphel…
Stakeholders have mixed reaction to CMS proposal to limit use of Alzheimer drug, Aduhelm
Reaction is mixed to the proposal by the Centers for Medicare and Medicaid Services to limit Medicare beneficiaries’ access to monoclonal antibody treatments that target amyloid for the treatment of Alzheimer’s, to those enrolled in qualifying clinical…
CMS proposes limiting Medicare coverage for the treatment of Alzheimer’s to clinical trials
The Centers for Medicare and Medicaid Services has released a proposed National Coverage Determination decision memorandum to cover Alzheimer’s treatment for people with Medicare, only if they are enrolled in clinical trials.
